HPRP-A1
General Information
DRACP ID DRACP00577
Peptide Name HPRP-A1
Sequence FKKLKKLFSKLWNWK
Sequence Length 15
UniProt ID Not available
PubChem CID Not available
Origin Synthetic
Type Synthetic peptide
Classification
Active ACP
Activity Information
Cell Line | Disease | Cancer Classified | Activity | Assay | Testing Time | Literature |
---|---|---|---|---|---|---|
B16 | Mouse melanoma | Carcinoma | IC50=6.1±0.02 μM | MTT assay | 24h | 1 |
SGC-7901 | Human papillomavirus-related endocervical adenocarcinoma | Carcinoma | IC50=5.2±0.14 μM | MTT assay | 24h | 1 |
Hep-G2 | Hepatoblastoma; Hepatoblastoma | Blastoma | IC50=7.7±0.23 μM | MTT assay | 24h | 1 |
HeLa | Human papillomavirus-related endocervical adenocarcinoma | Carcinoma | IC50=3.5±0.03 μM | MTT assay | 24h | 1 |
Hemolytic Activity Human RBC: MHC=64±6.80 μM
Normal (non-cancerous) Cytotoxicity Not available
Target Not available
Affinity Not available
Mechanism Not available
Nature Anticancer
Structure Information
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification Free
C-terminal Modification Free
Other Modification None
Chiral L
Physicochemical Information
Formula C101H156N24O18
Absent amino acids ACDEGHIMPQRTVY
Common amino acids K
Mass 224439
Pl 11.5
Basic residues 6
Acidic residues 0
Hydrophobic residues 7
Net charge 6
Boman Index -1796
Hydrophobicity -83.33
Aliphatic Index 78
Half Life
Mammalian: 30 hour
Yeast: >20 hour
E.coli: >10 hour
Extinction Coefficient cystines 11000
Absorbance 280nm 785.71
Polar residues 2
Amino acid distribution
Literature Information
Literature 1
Pubmed ID 26405806
Title TAT Modification of Alpha-Helical Anticancer Peptides to Improve Specificity and Efficacy
Doi 10.1371/journal.pone.0138911
Year 2015
Patent
Patent ID Not available
Patent Title Not available
Other Iinformation Not available
Other Published ID Not available